Human papillomavirus: local treatment of anogenital lesions

Khrianin A.A.; Reshetnikov O.V.; Lobzev N.V.; Perschetskaya E.B.; Esavulova L.T.; Givirovskiy S.E.

doi:https://doi.org/10.17116/klinderma2016156102-110

Khrianin A.A.

Novosibirsk State Medical University, Russian Ministry of Health and Social Development;
Association of Obstetricians, Gynecologists, and Dermatovenerologists, Novosibirsk

Reshetnikov O.V.

Research Institute of Therapy, Siberian Division of the Russian Academy of Medical Sciences

Lobzev N.V.

Sankt-Peterburgskij GBUZ KVD №7, Sankt-Peterburg, Rossija, 198260

Perschetskaya E.B.

Sankt-Peterburgskij GBUZ KVD №7, Sankt-Peterburg, Rossija, 198260

Esavulova L.T.

Sankt-Peterburgskij GBUZ KVD №7, Sankt-Peterburg, Rossija, 198260

Givirovskiy S.E.

Sankt-Peterburgskij GBUZ KVD №8, Sankt-Peterburg, Rossija, 195112

Human papillomavirus: local treatment of anogenital lesions

Authors:

Khrianin A.A., Reshetnikov O.V., Lobzev N.V., Perschetskaya E.B., Esavulova L.T., Givirovskiy S.E.

More about the authors

Journal: Russian Journal of Clinical Dermatology and Venereology. 2016;15(6): 102‑110

DOI: 10.17116/klinderma2016156102-110

Read: 6416 times

Download PDF (RU)

Contact the author

Table of contents

To cite this article:

Khrianin AA, Reshetnikov OV, Lobzev NV, Perschetskaya EB, Esavulova LT, Givirovskiy SE. Human papillomavirus: local treatment of anogenital lesions. Russian Journal of Clinical Dermatology and Venereology. 2016;15(6):102‑110. (In Russ.)
https://doi.org/10.17116/klinderma2016156102-110

Подписка 2026 Клиническая дерматология и венерология (Russian Journal of Clinical Dermatology and Venereology)

Использование инфографики авторами научных работ

Close metadata

Recommended articles:

Influence of griseofulvin on intestinal microbiota in the treatment of microsporia in rural children. Russian Journal of Clinical Dermatology and Venereology. 2025;(2):185-190

Results of the All-Russian consensus conference on complications in bariatric surgery. Endoscopic Surgery. 2025;(1):15-24

Features of the clinical course of biological subtypes of squamous cell oropharyngeal carcinoma. P.A. Herzen Journal of Oncology. 2025;(1):58-62

Combined treatment of patients with acute muscular tonic syndrome with dorsopathy. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(3):70-77

Characteristics, treatment features and in-hospital mortality of patients with myocardial infarction over 75 years old in Russia according to the REGION-IM registry. Russian Cardiology Bulletin. 2025;(1):22-38

Pharmacological treatment and prevention of ischemia-reperfusion syndrome in percutaneous coronary intervention. Russian Journal of Cardiology and Cardiovascular Surgery. 2025;(2):191-200

Stress and sleep: Neurobiological aspects and modern options of insomnia therapy. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(5-2):14-21

Cognitive impairment in patients with multiple sclerosis. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(4-2):67-73

Postoperative peritonitis: epidemiology, diagnosis, surgical treatment and prognosis. Pirogov Russian Journal of Surgery. 2025;(6):104-111

Early diagnosis and effective therapy of diabetic polyneuropathy. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(5):62-68

Abstract:

Current data on human papillomavirus are summarized. We discuss the epidemiology and clinical approaches to the diagnosis and treatment of patients with anogenital warts. High effectiveness of administration of imiquimod cream (Keravort) in the treatment of anogenital warts in males and females was exemplified by clinical cases.

Keywords:

human papillomavirus

anogenital warts

treatment

imiquimod

Keravort

Authors:

Khrianin A.A.

Novosibirsk State Medical University, Russian Ministry of Health and Social Development;
Association of Obstetricians, Gynecologists, and Dermatovenerologists, Novosibirsk

Reshetnikov O.V.

Research Institute of Therapy, Siberian Division of the Russian Academy of Medical Sciences

Lobzev N.V.

Sankt-Peterburgskij GBUZ KVD №7, Sankt-Peterburg, Rossija, 198260

Perschetskaya E.B.

Sankt-Peterburgskij GBUZ KVD №7, Sankt-Peterburg, Rossija, 198260

Esavulova L.T.

Sankt-Peterburgskij GBUZ KVD №7, Sankt-Peterburg, Rossija, 198260

Givirovskiy S.E.

Sankt-Peterburgskij GBUZ KVD №8, Sankt-Peterburg, Rossija, 195112

Close metadata

References:

Burchell AN, Winer RL, Sanjose S, Franco EL. Epidemiology and transmission dynamics of genital HPV infection. Vaccine 2006; 24: S3: 52-61.
Rakityanskaya IA, Kovelenov AY, Belozerov ES, Lyashenko YI. The defeat of the internal organs of viral and chlamydial infection in the practice of the therapist. Guidelines for doctors. St. Petersburg 2015:34-37. (in Russ.)
Zur Hausen H. Human pathogenic papillomaviruses, topics in microbiology and immunology. Berlin 1994; 186:131-157.
Parkin DM, Bray F. The burden of HPV-related cancers. Vaccine 2006; 24 (Suppl 3): S11–25.
IARC WHU Press Release 151 IARC confirms efficacy of cervix cancer screening for women 25-65 in reducing mortality, 03 May 2004.
Waggoner S. Cervical cancer. Lancet 2003; 361: 2217-2225.
Gravitt PE, Jamshidi R. Diagnosis and management of oncogenic cervical human papillomavirus infection. Infect Dis Clin North Am 2005; 19: 439–458.
McIntosh N. Human papillomavirus and cervical cancer. JHPIEGO Strategy Paper № 8, May 2000.
Partridge JM, Koutsky L. Genital human papillomavirus infection in men. Lancet Infectious Diseases 2006; 6: 21–31.
Patient management protocols. Sexually transmitted infections. M .: 2011. (in Russ.)
Khryanin AA, Reshetnikov OV. Human papillomavirus infection: a modern perspective on the epidemiology, prevention and treatment. Ginekol 2013; 15: 5: 4-8. (in Russ.)
Krogh von G, Lacey CJN, Gross G et al. European course on HPV associated pathology. Sex Transm Inf 2000; 76: 162-168.
Ferenczy A. Epidemiology and clinical pathophysiology of condylomata acuminate. Am J Obstet Gynecol 1995; 172: 1331-1339.
Koutsky L, Galloway D, Holmes K. Epidemiology of genital human papillomavirus infection. Epidemiol Rev 1988; 10: 122-163.
Stone KM. Human papillomavirus and genital warts: update on epidemiology and treatment. Clin Infect Dis 1995; 20: 91-97.
Heaton CL. Clinical manifestations and modern management of condylomata acuminate:a dermatologic perspective. Am J Obstet Gynecol 1995; 172: 1345-1350.
Fleurence RL, Dixon JM, Milanova TF, Beusterien KM. Review of the economic and quality-of-life burden of cervical human papillomavirus disease. Am J Obstet Gynecol 2007; 196: 206-212.
Eron SJ, Judson F, Tucker S et al. Inerferon therapy for condyloma acuminata. N Engl J Med 1986; 315: 1059-1064.
Friedman-Kein AE, Eron LJ, Conant M et al. Natural interferon alfa for treatment of condyloma acuminate. JAMA 1988; 259: 533-538.
Tyring SK, Arany I, Stanley MA. A randomized, controlled, molecular study of condylomata acuminate clearance drug treatment with imiquimod. J Infect Dis 1998; 178: 551-555.
Miller RL, Gerster JF, Owens MA et al. Imiquimod applied topically: a novel immune response modifier and new class of drag. Int J Immunopharmacol 1999; 21: 1-14.
Megyeri K, Au W-C, Rosztoczy I et al. Stimulation of interferon and cytokine gene expression by imiquimod and stimulation by Sendai virus utilize similar signal transduction pathways. Mol Cell Biol 1995; 15: 2207-2218.
Gibson SJ, Imbertson LM, Wagner TL et al. Cellular requirements for cytokine induction in response to the immunomodulators imiquimod and S-27609. Interferon Cytokine Res 1995; 15:537-545.
Testerman TL, Gerster JF, Imbertson LM et al. Cytokine induction by the immunomodulators imiquimod and S-27609. J Leukoc Biol 1995; 58: 365-372.
Stone KM. Human papillomavirus and genital warts: update on epidemiology and treatment. Clin Infect Dis 1995; 20: 91-97.
Heaton CL. Clinical manifestations and modern management of condylomata acuminate: a dermatologic perspective. Am J Obstet Gynecol 1995; 172: 1345-1350.
Bashi SA. Cryotherapy versus podophyllin in the treatment of genital warts. J Int Dermatol 1985; 24: 535-536.
Godley M, Bradbeer C, Gellan M, Thin RN. Cryotherapy compared with trichloroacetatic acid in treating genital warts. Genitourin Med 1987; 63: 390-392.
O’Mahony C, Law C, Gollnick HPM et al. Patients attitudes to genital wart therapies. Int J STD&AIDS 2001; 12: 567-570.
Rahmatulina MR, Kubanov AA, Samtsov AV et al. Clinical efficacy, safety and tolerability of Keravort cream (imiquimod) in the treatment of anogenital warts. Vestn dermatol venerol 2015; 1: 126-130. (in Russ.)
Rahmatulina MR, Semenenko AV. Comparative analysis of the methods of diagnosis and treatment of clinical manifestations of papillomavirus infection. Vestn dermatol venerol 2015; 1: 46-53. (in Russ.)
European STD Guidelines Int J STD AIDS 2001; 12 (suppl.3): 722-729.
CDC Recommendations and reports 2002; 51: RR-6: 53-57.
Clinical guidelines of RODVK. The management of STIs and reproductive tract infections. M .: 2013. (in Russ.)
AD Katsambas, TM Lotti (Eds.) European Handbook of Dermatological Treatments. 2014: 84-86. (in Russ.)
Khryanin AA, Klyuchareva SV, Baftalovskaya OA, Lobzev NV, Perschetskaya EB. Modern treatment of anogenital warts. Vestn dermatol venerol 2015; 5: 134-142. (in Russ.)